Terms: = Head and neck cancer AND MSH6, GTBP, P52701, 2956, ENSG00000116062, HSAP, HNPCC5 AND Diagnosis
16 results:
1. Somatic CDKN2A copy number variations are associated with the prognosis of esophageal squamous cell dysplasia.
Fan Z; Zhou J; Tian Y; Qin Y; Liu Z; Gu L; Dawsey SM; Wei W; Deng D
Chin Med J (Engl); 2024 Apr; 137(8):980-989. PubMed ID: 38445358
[TBL] [Abstract] [Full Text] [Related]
2. Muir-Torre syndrome and recent updates on screening guidelines: The link between colorectal tumors and sebaceous adenomas in unusual locations.
Shaker N; Shaker N; Abid A; Shah S; Shakra RA; Sangueza OP
J Surg Oncol; 2023 Dec; 128(8):1380-1384. PubMed ID: 37706607
[TBL] [Abstract] [Full Text] [Related]
3. Comparison of Clinical Outcomes, Pathologic Characteristics, and Immune-Related Features of Postradiation vs Sporadic Oral Cavity Squamous Cell Carcinoma.
Chow JCH; Cheuk W; Cho WCS; Wong CF; Au DWY; Tam AHP; Wong RCW; Chan JCH; Law SCC; Ngan RKC; Wong KH; Cheung KM
JAMA Netw Open; 2023 Jul; 6(7):e2323890. PubMed ID: 37459093
[TBL] [Abstract] [Full Text] [Related]
4. Using Proteome Microarray and Gene Expression Omnibus Database to Screen Tumour-Associated Antigens to Construct the Optimal Diagnostic Model of Oesophageal Squamous Cell Carcinoma.
Sun G; Ye H; Yang Q; Zhu J; Qiu C; Shi J; Dai L; Wang K; Zhang J; Wang P
Clin Oncol (R Coll Radiol); 2023 Oct; 35(10):e582-e592. PubMed ID: 37433700
[TBL] [Abstract] [Full Text] [Related]
5. Cathepsin F genetic mutation is associated with familial papillary thyroid cancer.
Wang Y; Mei J; Zhang Y; He X; Zheng X; Tan J; Jia Q; Li N; Li D; Wang Y; Meng Z
Am J Med Sci; 2022 Oct; 364(4):414-424. PubMed ID: 35447134
[TBL] [Abstract] [Full Text] [Related]
6. Efficacy of oral brush cytology cell block immunocytochemistry in the diagnosis of oral leukoplakia and oral squamous cell carcinoma.
Kujan O; Idrees M; Anand N; Soh B; Wong E; Farah CS
J Oral Pathol Med; 2021 May; 50(5):451-458. PubMed ID: 33368584
[TBL] [Abstract] [Full Text] [Related]
7. Clinicopathologic Features of Mismatch Repair-Deficient Anaplastic Thyroid Carcinomas.
Wong KS; Lorch JH; Alexander EK; Nehs MA; Nowak JA; Hornick JL; Barletta JA
Thyroid; 2019 May; 29(5):666-673. PubMed ID: 30869569
[No Abstract] [Full Text] [Related]
8. Clinico-pathological predictors of mismatch repair deficiency in sebaceous neoplasia: A large case series from a single Australian private pathology service.
Walsh MD; Jayasekara H; Huang A; Winship IM; Buchanan DD
Australas J Dermatol; 2019 May; 60(2):126-133. PubMed ID: 30506759
[TBL] [Abstract] [Full Text] [Related]
9. Microsatellite instability in metaplasia-dysplasia-adenocarcinoma sequence of Barrett esophagus: a retrospective study.
Markoš P; Brčić I; Brčić L; Jakić-Razumović J; Pulanić R
Croat Med J; 2018 Jun; 59(3):100-107. PubMed ID: 29972732
[TBL] [Abstract] [Full Text] [Related]
10. Cutaneous Metastasis of Adenocarcinoma of the Ampulla of Vater.
Fernandez-Flores A; Cassarino DS
Am J Dermatopathol; 2018 Oct; 40(10):758-761. PubMed ID: 29672360
[TBL] [Abstract] [Full Text] [Related]
11. Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1).
Harter P; Hauke J; Heitz F; Reuss A; Kommoss S; Marmé F; Heimbach A; Prieske K; Richters L; Burges A; Neidhardt G; de Gregorio N; El-Balat A; Hilpert F; Meier W; Kimmig R; Kast K; Sehouli J; Baumann K; Jackisch C; Park-Simon TW; Hanker L; Kröber S; Pfisterer J; Gevensleben H; Schnelzer A; Dietrich D; Neunhöffer T; Krockenberger M; Brucker SY; Nürnberg P; Thiele H; Altmüller J; Lamla J; Elser G; du Bois A; Hahnen E; Schmutzler R
PLoS One; 2017; 12(10):e0186043. PubMed ID: 29053726
[TBL] [Abstract] [Full Text] [Related]
12. A survey of the clinicopathological and molecular characteristics of patients with suspected Lynch syndrome in Latin America.
Rossi BM; Palmero EI; López-Kostner F; Sarroca C; Vaccaro CA; Spirandelli F; Ashton-Prolla P; Rodriguez Y; de Campos Reis Galvão H; Reis RM; Escremim de Paula A; Capochin Romagnolo LG; Alvarez K; Della Valle A; Neffa F; Kalfayan PG; Spirandelli E; Chialina S; Gutiérrez Angulo M; Castro-Mujica MDC; Sanchez de Monte J; Quispe R; da Silva SD; Rossi NT; Barletta-Carrillo C; Revollo S; Taborga X; Morillas LL; Tubeuf H; Monteiro-Santos EM; Piñero TA; Dominguez-Barrera C; Wernhoff P; Martins A; Hovig E; Møller P; Dominguez-Valentin M
BMC Cancer; 2017 Sep; 17(1):623. PubMed ID: 28874130
[TBL] [Abstract] [Full Text] [Related]
13. Analysis of Sebaceous Neoplasms for DNA Mismatch Repair Proteins in Muir-Torre Syndrome.
Pollinger TH; Kieliszak CR; Logemann N; Gratrix ML
Skinmed; 2017; 15(4):259-264. PubMed ID: 28859734
[TBL] [Abstract] [Full Text] [Related]
14. [Muir-Torre syndrome and Turcot syndrome].
Velter C; Caussade P; Fricker JP; Cribier B
Ann Dermatol Venereol; 2017; 144(8-9):525-529. PubMed ID: 28256262
[TBL] [Abstract] [Full Text] [Related]
15. cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry.
Pande M; Wei C; Chen J; Amos CI; Lynch PM; Lu KH; Lucio LA; Boyd-Rogers SG; Bannon SA; Mork ME; Frazier ML
Fam Cancer; 2012 Sep; 11(3):441-7. PubMed ID: 22714864
[TBL] [Abstract] [Full Text] [Related]
16. Agenesis of the corpus callosum and gray matter heterotopia in three patients with constitutional mismatch repair deficiency syndrome.
Baas AF; Gabbett M; Rimac M; Kansikas M; Raphael M; Nievelstein RA; Nicholls W; Offerhaus J; Bodmer D; Wernstedt A; Krabichler B; Strasser U; Nyström M; Zschocke J; Robertson SP; van Haelst MM; Wimmer K
Eur J Hum Genet; 2013 Jan; 21(1):55-61. PubMed ID: 22692065
[TBL] [Abstract] [Full Text] [Related]
